Tag: Perflutren

Serious cardiopulmonary reactions, including fatalities, have uncommonly occurred during or following the administration of perflutren-containing microspheres. Understanding the safety profile of perflutren, an ultrasound contrast agent, is crucial for patients undergoing echocardiograms to ensure proper safety measures are in place.

According to a clinical study published in the Journal of the American Society of Echocardiography, the use of Optison significantly increased the percentage of interpretable left ventricular segments in patients with suboptimal echocardiograms. This critical diagnostic tool helps physicians better understand heart conditions by revealing structures that are difficult to visualize with standard ultrasound alone. So, what is the drug Optison used for? In essence, it serves as an ultrasound contrast agent to enhance cardiac imaging.

Perflutren is an ultrasound contrast agent composed of gas-filled microspheres that significantly enhance the quality of echocardiograms, particularly for patients with suboptimal imaging. The medication works by reflecting sound waves, providing a clearer, more detailed picture of the heart's chambers and endocardial borders.